| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |